BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37976101)

  • 21. O-RADS MRI Classification of Indeterminate Adnexal Lesions: Time-Intensity Curve Analysis Is Better Than Visual Assessment.
    Wengert GJ; Dabi Y; Kermarrec E; Jalaguier-Coudray A; Poncelet E; Porcher R; Thomassin-Naggara I; Rockall AG;
    Radiology; 2022 Jun; 303(3):566-575. PubMed ID: 35230183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Study of the Efficacy of the Ovarian-Adnexa Reporting and Data System Ultrasound Combined With Contrast-Enhanced Ultrasound and the ADNEX MR Scoring System in the Diagnosis of Adnexal Masses.
    Wang T; Cui W; Nie F; Huang X; Huang L; Liu L; Zhu Y; Zheng R
    Ultrasound Med Biol; 2023 Sep; 49(9):2072-2080. PubMed ID: 37321953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups.
    Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
    JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interreader Agreement and Intermodality Concordance of O-RADS US and MRI for Assessing Large, Complex Ovarian-Adnexal Cysts.
    Guo Y; Phillips CH; Suarez-Weiss K; Roller LA; Frates MC; Benson CB; Shinagare AB
    Radiol Imaging Cancer; 2022 Sep; 4(5):e220064. PubMed ID: 36178350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of DWI and ADC values in Ovarian-Adnexal Reporting and Data System (O-RADS) MRI score.
    Manganaro L; Ciulla S; Celli V; Ercolani G; Ninkova R; Miceli V; Cozzi A; Rizzo SM; Thomassin-Naggara I; Catalano C
    Radiol Med; 2023 May; 128(5):565-577. PubMed ID: 37097348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Combing O-RADS US and CA-125 Improve Diagnostic Accuracy in Assessing Adnexal Malignancy Risk in Women With Different Menopausal Status?
    Wu M; Wang Q; Zhang M; Cao J; Chen Y; Zheng J; Luo L; Su M; Lin X; Kuang X; Zhang X
    J Ultrasound Med; 2023 Feb; 42(3):675-685. PubMed ID: 35880406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrast-enhanced US to Improve Diagnostic Performance of O-RADS US Risk Stratification System for Malignancy.
    Yuan K; Huang YJ; Mao MY; Li T; Wang SJ; He DN; Liu WF; Li MX; Zhu XM; Chen XY; Zhu YX
    Radiology; 2023 Aug; 308(2):e223003. PubMed ID: 37552073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the diagnostic efficiency between the O-RADS US risk stratification system and doctors' subjective judgment.
    Zhou S; Guo Y; Wen L; Liu J; Fu Y; Xu F; Liu M; Zhao B
    BMC Med Imaging; 2023 Nov; 23(1):190. PubMed ID: 37986051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee.
    Sadowski EA; Thomassin-Naggara I; Rockall A; Maturen KE; Forstner R; Jha P; Nougaret S; Siegelman ES; Reinhold C
    Radiology; 2022 Apr; 303(1):35-47. PubMed ID: 35040672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging modalities for the non-invasive diagnosis of endometriosis.
    Nisenblat V; Bossuyt PM; Farquhar C; Johnson N; Hull ML
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009591. PubMed ID: 26919512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive accuracy and reproducibility of the O-RADS US scoring system among sonologists with different training levels.
    Wu M; Zhang M; Cao J; Wu S; Chen Y; Luo L; Lin X; Su M; Zhang X
    Arch Gynecol Obstet; 2023 Aug; 308(2):631-637. PubMed ID: 35994107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
    Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
    Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Imaging].
    Abdel Wahab C; Rousset P; Bolze PA; Thomassin-Naggara I
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):260-276. PubMed ID: 32004779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses.
    Shi Y; Li H; Wu X; Li X; Yang M
    J Ovarian Res; 2023 Aug; 16(1):153. PubMed ID: 37537697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy and validity of the O-RADS MRI score based on a simplified MRI protocol: a single tertiary center retrospective study.
    Aslan S; Tosun SA
    Acta Radiol; 2023 Jan; 64(1):377-386. PubMed ID: 34839677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesions.
    Chen GY; Hsu TF; Chan IS; Liu CH; Chao WT; Shih YC; Jiang LY; Chang YH; Wang PH; Chen YJ
    Eur Radiol; 2022 Nov; 32(11):7854-7864. PubMed ID: 35583711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification.
    Pelayo M; Sancho-Sauco J; Sánchez-Zurdo J; Perez-Mies B; Abarca-Martínez L; Cancelo-Hidalgo MJ; Sainz-Bueno JA; Alcázar JL; Pelayo-Delgado I
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses.
    Basha MAA; Metwally MI; Gamil SA; Khater HM; Aly SA; El Sammak AA; Zaitoun MMA; Khattab EM; Azmy TM; Alayouty NA; Mohey N; Almassry HN; Yousef HY; Ibrahim SA; Mohamed EA; Mohamed AEM; Afifi AHM; Harb OA; Algazzar HY
    Eur Radiol; 2021 Feb; 31(2):674-684. PubMed ID: 32809166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Features of cystadenofibroma on magnetic resonance imaging: an update using the O-RADS lexicon and considering diffusion-weighted and perfusion imaging.
    Avesani G; Elia L; Anghelone AG; Perazzolo A; Panico C; Di Paola V; Gui B; Rodolfino E; Moro F; Testa AC; Manfredi R
    Eur J Radiol; 2022 Sep; 154():110429. PubMed ID: 35797789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical Tips for Reporting Adnexal Lesions Using O-RADS MRI.
    Suarez-Weiss KE; Sadowski EA; Zhang M; Burk KS; Tran VT; Shinagare AB
    Radiographics; 2023 Jul; 43(7):e220142. PubMed ID: 37319025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.